Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
148
datasets available to search
ShareScore release 0.9.0
Dataset results
148 results for “vemurafenib”
Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis
ClinicalTrials.gov study NCT02537600. IPD Sharing: NO. Countries: 1. Publications: 0.
An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)
ClinicalTrials.gov study NCT01990248. IPD Sharing: Not stated. Countries: 10. Publications: 0.
A Study of the Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy
ClinicalTrials.gov study NCT01851824. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy
ClinicalTrials.gov study NCT02968303. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer Patients
ClinicalTrials.gov study NCT01974258. IPD Sharing: Not stated. Countries: 1. Publications: 0.
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375)
GEO Series GSE83592. Homo sapiens. 16 samples. Type: Expression profiling by high throughput sequencing.
Reversing Vemurafenib-resistance in primary melanoma cells by combined Romidepsin and Type I IFN treatment through blocking of tumorigenic signals and induction of immunogenic effects
GEO Series GSE221386. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
Comparative gene expression profiling of parental A375 melanoma cells and a panel of spontaneously vemurafenib-resistant derivative cell lines
GEO Series GSE285131. Homo sapiens. 33 samples. Type: Expression profiling by high throughput sequencing.
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells
GEO Series GSE107370. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
Vemurafenib response and resistance analysis of metastatic melanomas with mutant and wild type BRAF
GEO Series GSE284250. Mus musculus. 24 samples. Type: Expression profiling by high throughput sequencing.
Indolium 1 Exerts Activity against Vemurafenib-Resistant Melanoma In Vivo
GEO Series GSE200882. Mus musculus. 4 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Human dermal fibroblasts (HDF), BRAF-V600E positive (MaMel21 and MaMel63a), and BRAF-WT malignant melanoma cell lines (SBcl2 and WM3438) after vemurafenib or DMSO treatment
GEO Series GSE188470. Homo sapiens. 64 samples. Type: Genome binding/occupancy profiling by high throughput sequencing; Expression profiling by high throughput sequencing.
RNA-seq for human dermal fibroblasts (HDF), BRAF-V600E positive (MaMel21 and MaMel63a), and BRAF-WT malignant melanoma cell lines (SBcl2 and WM3438) after vemurafenib or DMSO treatment
GEO Series GSE188469. Homo sapiens. 52 samples. Type: Expression profiling by high throughput sequencing.
Vemurafenib, BRAF inhibitor, Resistance in BRAFV600E Positive Thyroid Cancer cell lines
GEO Series GSE178267. Homo sapiens. 16 samples. Type: Expression profiling by high throughput sequencing.
Expression data from BRAFV600E A375 melanoma cells treated with vehicle or vemurafenib
GEO Series GSE42872. Homo sapiens. 6 samples. Type: Expression profiling by array.
ATAC-seq for human dermal fibroblasts (HDF) after vemurafenib or DMSO treatment
GEO Series GSE174669. Homo sapiens. 12 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Microarray expression data of A375 eIF4B-knockout (KO; KO/LacZ) and eIF4B-rescued (KO/eIF4B) cells with or without vemurafenib treatment
GEO Series GSE179452. Homo sapiens. 6 samples. Type: Expression profiling by array.
RNAseq changes in mouse wound with or without time course treatment by Vemurafenib
GEO Series GSE74558. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells
GEO Series GSE67088. Homo sapiens. 6 samples. Type: Expression profiling by array.
Comparison of tRNA abundance profiling in primary M395 melanoma cultures SENS or RES to 1µM Vemurafenib
GEO Series GSE236645. Homo sapiens. 6 samples. Type: Non-coding RNA profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.